Dr Lal Pathlabs Q2 Results 2025 Highlights: Net Profit Rises by 16.56% & Revenue Up 10.66% YoY

Click and Sign Up to Get Live Updates on Q2 Results 

Dr Lal Pathlabs Q2 Results FY26: During Q2 FY26, Dr Lal Pathlabs’s profit increased 16.56% YoY, while revenue increased by 10.66% YoY. The company posted robust numbers, with Q2 PAT at ₹150.60 crores and revenue at ₹730.60 crores. Dr Lal Pathlabs announced its Q2 results on 31st October 2025.  

Dr Lal Pathlabs Q2 Results FY26: Extracts of FY25 & FY26

Dr Lal Pathlabs Q2 Results FY26 Highlights (Q2 FY26 vs FY25)

• Dr Lal Pathlabs clocked Q2 FY26 consolidated revenue of ₹730.60 crores vs ₹660.20 crores. 
• On the profit front, Dr Lal Pathlabs earned a consolidated PAT of ₹150.60 crore in Q2 FY26. During FY25, the company’s PAT stood at ₹129.20 crore.
• According to the consolidated figures, Dr Lal Pathlabs’s quarterly PAT increased by 16.56% YoY, while revenue increased by 10.66%.
• Dr Lal Pathlabs clocked Q2 FY26 standalone revenue of ₹699.60 crores vs ₹630.90 crores. 
• On the profit front, Dr Lal Pathlabs earned a standalone PAT of ₹145.70 crore in Q2 FY26. During FY25, the company’s PAT stood at ₹128.80 crore.
• According to the standalone figures, Dr Lal Pathlabs’s quarterly PAT increased by 13.12% YoY, while revenue increased by 10.89%.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!

About Dr Lal Pathlabs Limited

Dr Lal Pathlabs was established in 1949. It is a large and respected diagnostic service provider in India that offers a wide range of pathology, radiology, and cardiology services, including routine and specialised tests. The company has a pan-India presence, with numerous labs and centres, focusing on preventive healthcare and early disease detection. The company has served millions of customers and has a presence in countries such as Nepal and Bangladesh.   

Dr Lal Pathlabs Share Price Performance

On the opening bell on 3rd November 2025, Dr Lal Pathlabs shares opened at ₹3,151.10 per share. However, the initial gains have since eroded, and Dr Lal Pathlabs shares are currently trading at ₹3,261.90 per share, which is higher than the opening price.    

Considering the long-term achievements, Dr Lal Pathlabs shares have yielded returns of approximately 6.20% over the past years, and 5-year returns stand at 40.77%. Over the maximum timeframe, Dr Lal Pathlabs shares delivered a 264.14% return to investors. 

What Analysts Expect Post Q2 Results?

Following Dr Lal Pathlabs’s robust Q2 results, analysts expect its share price to rise. According to analysts, Dr Lal Pathlabs’ share price could reach ₹3,390.20 per share in the coming year and, in a downturn, could fall to ₹3,235.20 per share. However, one must ignore stock market volatility and invest in Dr Lal Pathlabs’s shares after thorough research. 

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.

Recent Articles

Nestle Q2 Results FY26: Q2 PAT Falls 17.38% to ₹743.17 Crore; Revenue Up 10.57% YoY

Inspira Enterprise India IPO Details: Everything You Should Know about 

Swaraj Engines Q2 Results FY26: Q2 PAT Rises 8.88% to ₹49 Crore; Revenue Up 8.62% YoY

HDB Financial Q2 Results FY26: Q2 PAT Falls 1.5% to ₹581 Crore; Revenue Up 13.42% YoY

BEL Gears Up for Q2 Reveal on 4th November; Check Key Expectations Here

Paytm Gears Up for Q2 Reveal on 4th November; Check Key Expectations Here

Blue Dart Gears Up for Q2 Reveal on 28th October; Check Key Expectations Here